Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease

about
author
inLanguage
  • en
isPartOf
name
  • Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease
  • Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease
P60049

Instances

Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease

description
  • Julkaistu myös painettuna ISBN 978-952-10-8401-0
isPartOf
name
  • Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease

Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease

description
  • Yhteenveto-osa julkaistu myös verkkoaineistona ISBN 978-952-10-8402-7 (PDF)
isPartOf
name
  • Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease

Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease

bookFormat
isPartOf
name
  • Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease
url

Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease

datePublished
  • 2012
description
  • Artikkeliväitöskirjan yhteenveto-osa ja 4 eripainosta.
  • kuvitettu
  • Nimiösivulla myös: Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
identifier
  • propertyID: FI-FENNI value: 1005365
  • propertyID: FI-MELINDA value: 006089341
  • propertyID: skl value: fx1005365
isbn
  • 9789521084010
isPartOf
name
  • Aberrant kinase activation as a therapy target : chronic myeloid leukemia as a model disease
numberOfPages
  • 79, [41] sivu
P60048
P60050
publication
  • location: Helsinki organizer: Helsingin yliopisto
publisher

Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease

bookFormat
datePublished
  • 2012
description
  • Artikkeliväitöskirjan yhteenveto-osa.
  • Nimeke PDF-nimiönäytöstä.
  • Nimiösivulla myös: Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
identifier
  • propertyID: FI-FENNI value: 1005366
  • propertyID: FI-MELINDA value: 006089342
  • propertyID: skl value: fx1005366
isbn
  • 9789521084027
isPartOf
name
  • Aberrant kinase activation as a therapy target: Chronic myeloid leukemia as a model disease
numberOfPages
  • 1 PDF-tiedosto (79 s.)
P60048
P60050
publication
  • location: Helsinki organizer: Helsingin yliopisto
publisher
url

Download this resource as RDF: